NextDocs announced it has formed a partnership with Information Services International-Dentsu, Ltd.
NextDocs Corporation, a provider of regulated content management and compliance solutions for the life sciences industry, announced it has formed a partnership with Information Services International-Dentsu, Ltd. (ISID), an IT solutions provider in Japan, for the delivery of NextDocs document management solutions for life science companies. Under the partnership agreement, ISID will provide marketing, sales, professional services and support for NextDocs Enterprise Content Management (ECM) platform for Clinical Trials, Regulatory Document Management, and Quality Management Systems to life sciences companies in Japan. ISID will offer customers full delivery services including integration, migration and design for the NextDocs ECM platform. In addition, NextDocs and ISID will co-invest in marketing, sales, training and development including local language support to offer higher values for life science companies.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.